Medicines Value Programme Patient Groups Meeting
All booking fees included.
Ticket sales have finished for this event.
We invite you to join us to discuss NHS England's and NHS Improvement's plans for medicines and pharmacy across all parts of the NHS. We hold these meetings twice a year to share our work and engage with patient groups to make sure we are focused on the patient perspective at all times.
The third Medicines Value Programme patient groups meeting will be chaired by Bruce Warner, the Deputy Chief Pharmaceutical Officer for NHS England. Following the discussion in the last session about how the NHS is working to bring best value biological medicines into the NHS, this session will focus on adalimumab which is used to treat conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease.
We will also discuss how we are working to improve medicines safety across the healthcare system, including a focus on the Medicines Optimisation in Care Homes programme which is set to deploy pharmacists and pharmacy technicians in to care homes this year to improve shared decision-making around medicines and work towards better outcomes for frail and elderly patients.
We hope you will be able to join us to share your thoughts on our plans.
- Introduction, including an update on the 10 year plan - Bruce Warner, Deputy Chief Pharmaceutical Officer, NHS England
- Best value biologicals - Adalimumab - Steve Brown, Regional Pharmacist, NHS Improvement + Helen McAteer, CE of Psoriasis Association
- Medicines safety – Sabina Khanom, Patient Safety Policy Lead (Primary Care), NHS Improvement + Graham Prestwich, Me and My Medicines
- Care homes medicines optimisation - Wasim Baqir, Pharmacy Integration Care Homes Lead, NHS England
- Polypharmacy - Clare Howard, Wessex AHSN